Title:
CRYSTAL FORM OF ACID ADDITION SALT OF PUROPYRIMIDINE COMPOUND
Document Type and Number:
WIPO Patent Application WO/2020/204426
Kind Code:
A1
Abstract:
One embodiment relates to: a crystal form of an acid addition salt of N-(3-(2-(4-(4-methylpiperazine-1-yl)phenylamino)puro[3,2-d]pyrimidine-4-yloxy)phenyl)acrylamide; and a pharmaceutical composition comprising same. The crystal form can be easily used in the preparation of a pharmaceutical composition comprising same as an active ingredient.
Inventors:
OH HEE SOOK (KR)
JUNG JAE HYUK (KR)
JEON JI YOUNG (KR)
JANG SUN YOUNG (KR)
HA TAE HEE (KR)
JUNG JAE HYUK (KR)
JEON JI YOUNG (KR)
JANG SUN YOUNG (KR)
HA TAE HEE (KR)
Application Number:
PCT/KR2020/003850
Publication Date:
October 08, 2020
Filing Date:
March 20, 2020
Export Citation:
Assignee:
HANMI PHARM IND CO LTD (KR)
International Classes:
C07D491/04; A61K31/519; A61P29/00; A61P35/00; A61P37/00
Domestic Patent References:
| WO2017218844A2 | 2017-12-21 | |||
| WO2016174183A1 | 2016-11-03 |
Foreign References:
| KR101589114B1 | 2016-01-29 | |||
| KR20180089903A | 2018-08-09 | |||
| KR20180089904A | 2018-08-09 | |||
| KR101589114B1 | 2016-01-29 | |||
| KR20110162515A |
Other References:
See also references of EP 3936506A4
Attorney, Agent or Firm:
Y.P.LEE, MOCK & PARTNERS (KR)
Download PDF: